Bae, Woo Kyun <br/><br/>
The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.  [electronic resource] 

 -  Molecular carcinogenesis  Oct 2015 
 - 1172-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-2744 
<br/><br/><label>Standard No.: </label>10.1002/mc.22188  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>BRCA1 Protein--metabolism<br/>Breast--metabolism<br/>Breast Neoplasms--metabolism<br/>Enhancer of Zeste Homolog 2 Protein<br/>Female<br/>Humans<br/>Jumonji Domain-Containing Histone Demethylases--metabolism<br/>Methyltransferases--metabolism<br/>Mice<br/>Middle Aged<br/>Polycomb Repressive Complex 2--metabolism<br/>Prognosis<br/>Receptors, Estrogen--metabolism<br/>Young Adult